Viewing Study NCT07225504


Ignite Creation Date: 2025-12-24 @ 9:20 PM
Ignite Modification Date: 2025-12-26 @ 9:45 AM
Study NCT ID: NCT07225504
Status: RECRUITING
Last Update Posted: 2025-12-24
First Post: 2025-11-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module